Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2025-12-25 @ 4:46 AM
NCT ID:
NCT05942118
Eligibility Criteria:
Inclusion Criteria:
* Female;
* Non-palpable breast lesions;
* Indication to lesion's surgical excision (lumpectomy, quadrantectomy)
* Preoperative diagnosis on histology or cytology of borderline lesion (B3 or C3) or malignant lesion (B4-B5 or C4-C5);
* Written informed consent.
Exclusion Criteria:
* Benign lesion at diagnosis on preoperative core biopsy (B2) or fine needle aspiration (C2);
* Clinically palpable breast lesion;
* Breast lesion localization for planned neoadjuvant chemotherapy.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05942118
Study Brief:
Protocol Section:
NCT05942118